"Over the last 20 years, we've partnered with the CDMRP to develop and deploy a world-class approach for engaging scientists, clinicians, and consumers in the evaluation of grant applications," said Paul Nedzbala, CSRA's executive vice president, Health and Civil group. "Bringing an outstanding team of subject matter experts together with survivors and caregivers has been instrumental in ensuring funding of innovative research with the potential to make a real impact on peoples' lives."
Under the contract, CSRA will continue to support all facets of grant application receipt and scientific evaluation, leveraging the company's industry-leading peer review technology platform, P²RMIS®. CSRA will recruit, train and engage scientists, clinicians, and specialists to serve on review panels; provide logistics support to panel participants; and maintain the CDMRP's electronic Biomedical Research Application Portal, eBRAP.
"This award is a critically important win for CSRA and cements our position as the pre-eminent provider of scientific peer review solutions," said Nedzbala.
About CSRA Inc.
Every day CSRA (NYSE: CSRA) makes a difference in how the government serves our country and our citizens. We deliver a broad range of innovative, cloud-enabled, next-generation IT solutions and professional services to help our customers modernize their legacy systems, protect their applications, infrastructure, and assets and improve the effectiveness and efficiency of mission-critical functions for our warfighters and our citizens. Our 18,000 employees understand that success is a matter of perseverance, courage, adaptability and experience. CSRA is headquartered in Falls Church, Virginia. To learn more about CSRA, visit www.csra.com.
All statements in this press release and in all future press releases that do not directly and exclusively relate to historical facts constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements represent CSRA's intentions, plans, expectations and beliefs, including statements about network and asset protection and improving mission-critical functions. The forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside the control of CSRA. These factors could cause actual results to differ materially from forward-looking statements. For a written description of these factors, see the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in CSRA's most recent Annual Report on Form 10-K and any updating information in subsequent SEC filings. CSRA disclaims any intention or obligation to update these forward-looking statements whether as a result of subsequent event or otherwise, except as required by law.
Logo - http://photos.prnewswire.com/prnh/20151207/293934LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/csra-helps-advance-medical-research-300295029.html
SOURCE CSRA Inc.